New Approaches to Cardiovascular Disease and Its Management in Kidney Transplant Recipients : Transplantation

Journal Logo

Reviews

New Approaches to Cardiovascular Disease and Its Management in Kidney Transplant Recipients

Aziz, Fahad MD1; Jorgenson, Margaret PharmD, BCPS2; Garg, Neetika MD1; Parajuli, Sandesh MD1; Mohamed, Maha MD1; Raza, Farhan MD3; Mandelbrot, Didier MD1; Djamali, Arjang MD1,4; Dhingra, Ravi MD, MPH3

Author Information
Transplantation 106(6):p 1143-1158, June 2022. | DOI: 10.1097/TP.0000000000003990

Abstract

Erratum

In the article “New Approaches to Cardiovascular Disease and its Management in Kidney Transplant Recipients” by Aziz et al, which published in the June 2022 issue of Transplantation, an error was introduced on page 1150 in the following sentence: In the concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer trial, 830 KTRs on maintenance CNIs, who had a kidney transplant 6 to 120 mo earlier, were randomized to remain on CNI

or convert to sirolimus. The correct sentence should read as: In the CONVERT trial, 830 KTRs on maintenance CNIs, who had a kidney transplant 6 to 120 mo earlier, were randomized to remain on CNI or convert to sirolimus.

The authors apologize for the error.

Transplantation. 106(9):e429, September 2022.

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid